A combination of conventional and advanced imaging is required for complete characterization
of spinal metastases before and after treatment.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Clinical RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Bone metastases radiopharmaceuticals: an overview.Curr Radiopharm. 2013; 6: 41-47
- Diagnostic imaging and image-guided therapy of skeletal metastases.Cancer Control. 2012; 19: 102-112
- Detection of osseous metastases of the spine: comparison of high resolution multi-detector-CT with MRI.Eur J Radiol. 2009; 69: 567-573
- Contrast-enhanced Dixon fat-water separation imaging of the spine: added value of fat, in-phase and opposed-phase imaging in marrow lesion detection.J Comput Assist Tomogr. 2016; 40: 985-990
- Metal-related artifacts in instrumented spine. Techniques for reducing artifacts in CT and MRI: state of the art.Eur Spine J. 2009; 18: 102-108
- Optimized imaging of the postoperative spine.Neuroimaging Clin N Am. 2014; 24: 349-364
- Differentiation of myeloma and metastatic cancer in the spine using dynamic contrast-enhanced MRI.Magn Reson Imaging. 2013; 31: 1285-1291
- The promise of dynamic contrast-enhanced imaging in radiation therapy.Semin Radiat Oncol. 2011; 21: 147-156
- Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications.J Magn Reson Imaging. 1996; 6: 311-321
- Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.Eur J Radiol. 2013; 82: 1444-1452
- Pixel-by-pixel analysis of DCE MRI curve patterns and an illustration of its application to the imaging of the musculoskeletal system.Magn Reson Imaging. 2007; 25: 604-612
- Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.J Magn Reson Imaging. 1997; 7: 91-101
- Measurement of blood perfusion in spinal metastases with dynamic contrast-enhanced magnetic resonance imaging: evaluation of tumor response to radiation therapy.Spine. 2013; 38: E1418-E1424
- Magnetic resonance perfusion characteristics of hyper-vascular renal and hypovascular prostate spinal metastases: clinical utilities and implications.Spine (Phila Pa 1976). 2014; 39: E1433-E1440
- A pilot study evaluating the use of dynamic contrast-enhanced perfusion MRI to predict local recurrence after radiosurgery on spinal metastases.Technol Cancer Res Treat. 2017; 16: 857-865
- Diffusion-weighted MR imaging of bone marrow: differentiation of benign versus pathologic compression fractures.Radiology. 1998; 207: 349-356
- Diffusion-weighted MR imaging offers no advantage over routine noncontrast MR imaging in the detection of vertebral metastases.AJNR Am J Neuroradiol. 2000; 21: 948-953
- Diagnostic value of increased diffusion weighting of a steady-state free precession sequence for differentiating acute benign osteoporotic fractures from pathologic vertebral compression fractures.AJNR Am J Neuroradiol. 2001; 22: 366-372
- Research synthesis: what is the diagnostic performance of magnetic resonance imaging to discriminate benign from malignant vertebral compression fractures? Systematic review and meta-analysis.Spine. 2012; 37: E736-E744
- Clinical applications of diffusion imaging in the spine.Magn Reson Imaging Clin N Am. 2013; 21: 299-320
- Differentiation of acute osteoporotic and malignant compression fractures of the spine: use of additive qualitative and quantitative axial diffusion-weighted MR imaging to conventional MR imaging at 3.0 T.Radiology. 2014; 271: 488-498
- Diffusion-weighted MR imaging of metastatic disease of the spine: assessment of response to therapy.AJNR Am J Neuroradiol. 2002; 23: 906-912
- Whole-body diffusion-weighted MR imaging in cancer: current status and research directions.Radiology. 2011; 261: 700-718
- Vertebral metastases: assessment with apparent diffusion coefficient.Radiology. 2002; 225: 889-894
- Multiple myeloma and dual-energy CT: diagnostic accuracy of virtual noncalcium technique for detection of bone marrow infiltration of the spine and pelvis.Radiology. 2018; 286: 205-213
- Spine Oncology: Imaging and Intervention.Radiol Clin North Am. 2019; 57: 377-395
- Current and novel techniques for metal artifact reduction at CT: practical guide for radiologists.Radiographics. 2018; 38: 450-461
- Spine oncology-metastatic spine tumors.Neurosurgery. 2017; 80: S131-S137
- Imaging of spinal metastatic disease.Int J Surg Oncol. 2011; 2011: 769753
- The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.J Nucl Med. 2006; 47: 287-297
- Malignant versus benign vertebral collapse: are new imaging techniques useful?.Cancer Imaging. 2009; 9: S49-S51
- Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures.J Neurosurg Spine. 2011; 14: 177-183
- PET imaging of skeletal metastases and its role in personalizing further management.PET Clin. 2016; 11: 305-318
- Molecular imaging in oncology: (18)F-sodium fluoride PET imaging of osseous metastatic disease.AJR Am J Roentgenol. 2014; 203: 263-271
- Integrating evidence-based medicine for treatment of spinal metastases into a decision framework: neurologic, oncologic, mechanicals stability, and systemic disease.J Clin Oncol. 2017; 35: 2419-2427
- Current paradigms for metastatic spinal disease: an evidence-based review.Ann Surg Oncol. 2014; 21: 248-262
- The NOMS framework: approach to the treatment of spinal metastatic tumors.Oncologist. 2013; 18: 744-751
- Contemporary treatment strategy for spinal metastasis: the “LMNOP” system.Can J Neurol Sci. 2011; 38: 396-403
- State of the art treatment of spinal metastatic disease.Neurosurgery. 2018; 82: 757-769
- A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group.Spine. 2010; 35: E1221-E1229
- Reliability of the spinal instability neoplastic scale among radiologists: an assessment of instability secondary to spinal metastases.AJR Am J Roentgenol. 2014; 203: 869-874
- Novel MRI-based score for assessment of bone density in operative spine patients.Spine J. 2020; 20: 556-562
- Vertebral compression fracture after spine stereotactic body radiation therapy: a review of the pathophysiology and risk factors.Neurosurgery. 2018; 83: 314-322
- Reliability analysis of the epidural spinal cord compression scale.J Neurosurg Spine. 2010; 13: 324-328
- Spine metastases: from radiotherapy, surgery, to radiosurgery.Neurosurgery. 2014; 61: 16-25
- Vertebroplasty technique in metastatic disease.Neuroimaging Clin N Am. 2010; 20: 169-177
- Sacral fractures and sacroplasty.Neuroimaging Clin N Am. 2019; 29: 515-527
- Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial.Cancer. 2010; 116: 989-997
- Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why.Radiographics. 2014; 34: 1344-1362
- Use of imaging in the management of metastatic spine disease with percutaneous ablation and vertebral augmentation.AJR Am J Roentgenol. 2015; 205: 434-441
Article info
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
